BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2015
View Archived Issues
New murine models of autosomal dominant temporal lobe epilepsy
Read More
Periostin shows promise as a differential diagnostic marker
Read More
Novel thienopyrimidinone PDE7 inhibitors discovered at Kaken
Read More
New role suggested for Nkx-3.1 as a biomarker in male breast carcinoma
Read More
Health Canada clears Hydra to begin phase I study of HX-100
Read More
Merck & Co. presents novel MR antagonists
Read More
Godavari Biorefineries discloses novel antineoplastics
Read More
Shanghai Yingli patents new PI3Kdelta inhibitors
Read More
Theravectys gains exclusive license to Institut Curie's library of synthetic humanized nanobodies
Read More
RegImmune, JDRF and Pfizer team up to develop antigen-specific immunotherapy for type 1 diabetes
Read More
Identification of a selective, small-molecule DYRK1A inhibitor
Read More
MSD and Astellas Pharma combine forces against type 2 diabetes in Japan
Read More
Primary endpoint met in phase IIb trial of JAK1 inhibitor for rheumatoid arthritis
Read More
Effimune gets go-ahead for phase I trial of immunomodulatory antibody
Read More
Critical Path Institute's skeletal muscle safety markers supported by regulatory agencies
Read More
Compugen gains rights to use NIH biological systems and materials
Read More
FDA advisory committee says alogliptin, saxagliptin have acceptable CV risk profiles
Read More
Novel biomarkers for neuroendocrine tumors
Read More
Roche and Genentech patent CDK8 inhibitors
Read More
University of Basel and PIQUR Therapeutics disclose PI3Kalpha/mTOR nhibitors
Read More
Bayer Schering Pharma patents FXIa inhibitors
Read More
FDA sets review action date for Repros' enclomiphene citrate NDA
Read More
FDA advisory committee recommends approval of cangrelor for use in PCI
Read More
FDA approves Amgen's ivabradine for chronic heart failure
Read More
Active Biotech and Ipsen discontinue development of tasquinimod for prostate cancer
Read More
BMS and Lexicon select neuropathic pain candidate
Read More
Senju licenses Asian rights to Eyenovia ophthalmic delivery technology
Read More
China FDA clears IND for development of DP-VPA through phase III for epilepsy
Read More
